These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 6150862

  • 1. 5HT-receptor antagonist properties of SCH 23390 in vascular smooth muscle and brain.
    Hicks PE, Schoemaker H, Langer SZ.
    Eur J Pharmacol; 1984 Oct 15; 105(3-4):339-42. PubMed ID: 6150862
    [Abstract] [Full Text] [Related]

  • 2. The D-1 dopamine receptor antagonist SCH 23390 also interacts potently with brain serotonin (5-HT2) receptors.
    Bischoff S, Heinrich M, Sonntag JM, Krauss J.
    Eur J Pharmacol; 1986 Oct 07; 129(3):367-70. PubMed ID: 3536532
    [Abstract] [Full Text] [Related]

  • 3. Interaction of the D1 receptor antagonist SCH 23390 with the central 5-HT system: radioligand binding studies, measurements of biochemical parameters and effects on L-5-HTP syndrome.
    Bischoff S, Heinrich M, Krauss J, Sills MA, Williams M, Vassout A.
    J Recept Res; 1988 Oct 07; 8(1-4):107-20. PubMed ID: 3290470
    [Abstract] [Full Text] [Related]

  • 4. A comparison of the selectivities of SCH 23390 with BW737C89 for D1, D2 and 5-HT2 binding sites both in vitro and in vivo.
    Riddall DR.
    Eur J Pharmacol; 1992 Jan 21; 210(3):279-84. PubMed ID: 1351844
    [Abstract] [Full Text] [Related]

  • 5. SCH 23390 and SK&F 83566 are antagonists at vascular dopamine and serotonin receptors.
    Ohlstein EH, Berkowitz BA.
    Eur J Pharmacol; 1985 Jan 22; 108(2):205-8. PubMed ID: 3884345
    [Abstract] [Full Text] [Related]

  • 6. Peripheral dopamine receptor blockade by SCH 23390 and domperidone in vitro.
    Hilditch A, Drew GM.
    Eur J Pharmacol; 1985 Oct 08; 116(1-2):171-4. PubMed ID: 2865160
    [Abstract] [Full Text] [Related]

  • 7. [3H]SCH 23390 labels a novel 5-hydroxytryptamine binding site in human blood platelet membranes.
    De Keyser J, Walraevens H, Convents A, Ebinger G, Vauquelin G.
    Eur J Pharmacol; 1989 Mar 29; 162(3):437-45. PubMed ID: 2568263
    [Abstract] [Full Text] [Related]

  • 8. Typical and atypical antipsychotic drugs are potent antagonists of the relaxant 5-hydroxytryptamine receptor in the smooth muscle of canine coronary artery.
    Terrón JA.
    Proc West Pharmacol Soc; 1996 Mar 29; 39():23-5. PubMed ID: 8895957
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Interaction of SCH 23390, a D-1-selective antagonist, with the anterior pituitary D-2 receptors and prolactin secretion in the rat.
    Apud JA, Masotto C, Ongini E, Racagni G.
    Eur J Pharmacol; 1985 Jun 07; 112(2):187-93. PubMed ID: 2863153
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. In vitro studies with ICI 169,369, a chemically novel 5-HT antagonist.
    Blackburn TP, Thornber CW, Pearce RJ, Cox B.
    Eur J Pharmacol; 1988 Jun 10; 150(3):247-56. PubMed ID: 3416910
    [Abstract] [Full Text] [Related]

  • 14. Effect of SCH 39166, a novel dopamine D1 receptor antagonist, on [3H]acetylcholine release in rat striatal slices.
    Tedford CE, Crosby G, Iorio LC, Chipkin RE.
    Eur J Pharmacol; 1992 Feb 11; 211(2):169-76. PubMed ID: 1535318
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. 5-HT2 receptor regulation of acetylcholine release induced by dopaminergic stimulation in rat striatal slices.
    Ramírez MJ, Cenarruzabeitia E, Lasheras B, Del Rio J.
    Brain Res; 1997 May 16; 757(1):17-23. PubMed ID: 9200494
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the pharmacological characteristics of [3H]raclopride and [3H]SCH 23390 binding to dopamine receptors in vivo in mouse brain.
    Andersen PH.
    Eur J Pharmacol; 1988 Jan 27; 146(1):113-20. PubMed ID: 2895008
    [Abstract] [Full Text] [Related]

  • 18. 5-HT2-receptor antagonists: alpha 1- vs. 5-HT2-receptor blocking properties in blood vessels.
    Cohen ML, Schenck KW, Kurz KD.
    J Cardiovasc Pharmacol; 1988 Jan 27; 11 Suppl 1():S25-9. PubMed ID: 2459510
    [Abstract] [Full Text] [Related]

  • 19. Preclinical pharmacology of a new serotonergic receptor antagonist, LY281067.
    Cohen ML, Fuller RW, Kurz KD, Parli CJ, Mason NR, Meyers DB, Smallwood JK, Toomey RE.
    J Pharmacol Exp Ther; 1988 Jan 27; 244(1):106-12. PubMed ID: 3335993
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.